Stimcell Energetics Inc. (STME) stock
STMEOTCSurgical & Medical Instruments & ApparatusFiscal year ends May 31
$0.16−0.07 (-29.57%)
Close on Oct 19, 2026Market cap $3.42MP/E –Yield –
Stimcell Energetics r&d expenses
Research and development expenses are spending on new products and technology.
Stimcell Energetics's R&D Expenses for the twelve months ending Aug 31, 2023 was $66.68K. For fiscal 2023 it was $89.22K, down 40.8% from the year before. The highest annual figure on record is $650.38K in fiscal 2016.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | May 31, 2023 | $89.22K | -40.8% |
| FY2022 | May 31, 2022 | $150.71K | -34.4% |
| FY2021 | May 31, 2021 | $229.58K | -41.6% |
| FY2020 | May 31, 2020 | $393.22K | +50.1% |
| FY2019 | May 31, 2019 | $261.91K | -37.4% |
| FY2018 | May 31, 2018 | $418.32K | +40.8% |
| FY2017 | May 31, 2017 | $297.04K | -54.3% |
| FY2016 | May 31, 2016 | $650.38K | +265.7% |
| FY2015 | May 31, 2015 | $177.87K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | $306 | -98.7% |
| Q4 FY2023CQ2 2023 | May 31, 2023 | $424 | -98.7% |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | $43.55K | +21.5% |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | $22.41K | -37.3% |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | $22.84K | -67.4% |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | $31.46K | -18.4% |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | $35.84K | -57.9% |
| Q4 FY2021CQ2 2021 | May 31, 2021 | $35.76K | -72.0% |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | $70.15K | -35.7% |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | $38.54K | +165.7% |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | $85.14K | +33.0% |
| Q4 FY2020CQ2 2020 | May 31, 2020 | $127.49K | -41.6% |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | $109.12K | -1.8% |
| Q4 FY2019CQ2 2019 | May 31, 2019 | $14.51K | -78.4% |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | $64.03K | -12.1% |
| Q4 FY2018CQ2 2018 | May 31, 2018 | $218.15K | +289.5% |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | $111.17K | +610.7% |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | $67.17K | +166.7% |
| Q1 FY2017CQ3 2016 | Aug 31, 2016 | $72.85K | -86.8% |
| Q4 FY2016CQ2 2016 | May 31, 2016 | $56.01K | +77.2% |
| Q3 FY2016CQ1 2016 | Feb 29, 2016 | $15.64K | -89.3% |
| Q2 FY2016CQ4 2015 | Nov 30, 2015 | $25.19K | – |
| Q1 FY2016CQ3 2015 | Aug 31, 2015 | $553.54K | – |
| Q4 FY2015CQ2 2015 | May 31, 2015 | $31.61K | – |
| Q3 FY2015CQ1 2015 | Feb 28, 2015 | $146.26K | – |
See a number that looks wrong?